FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Testosterone Cypionate Injection Recall

Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Jun 29, 2022
Recall ID
D-1153-2022
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Testosterone Cypionate Injection starting Jun 3, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1153-2022 on Jun 29, 2022. Reason: CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities. Status: Terminated.

Why it was recalled

CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.

Product description

Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-015-40.

Lot numbers, UPCs & expiration codes

HAC1974A, HAC1978A, Exp 06/2023

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1153-2022
Classification
Class II
Status
Terminated
Recall initiated
Jun 3, 2022
FDA report date
Jun 29, 2022
Quantity
97,450 vials
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-1153-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
90361
Address
2 Independence Way
Code information
HAC1974A, HAC1978A, Exp 06/2023
Postal code
08540-6620
Report date
Jun 29, 2022
Product type
Drugs
Recall number
D-1153-2022
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
97,450 vials
Termination date
May 24, 2023
Reason for recall
CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-015-40.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Jun 3, 2022
Center classification date
Jun 21, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1153-2022, published Jun 29, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls